Latest Breaking News On - Company wide blackout restricting - Page 1 : comparemela.com

/PRNewswire/ Inhibrx, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a biopharmaceutical company with three clinical programs in development and a strong.

Jon faiz kayyemKimberly manhardDouglas forsythSecurities exchangeAventis incInhibrx incParty transactionsCompany onInhibrx biosciences incPrnewswire inhibrx incExchange commissionInhibrx biosciencesNew inhibrxCompany employeesCurrently subjectCompany wide blackout restricting